MONICA JOOSTEN: Open Payments
NPI 1750916094 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 41 payments from 14 companies in 2025. Trend: 2023 $1,398 · 2024 $1,699 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $177 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Lilly USA, LLC | 5 | $97 |
| Axsome Therapeutics, Inc. | 1 | $97 |
| Sumitomo Pharma America, Inc. | 4 | $92 |
| Novo Nordisk Inc | 3 | $63 |
| ABIOMED | 2 | $49 |
| Nalu Medical, Inc. | 1 | $35 |
| Viatris Specialty LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
Products named: JARDIANCE, Auvelity, GEMTESA, MOUNJARO, Ozempic, BREZTRI, FARXIGA, Nalu Neurostimulation System.
Industry payments across CA — which companies pay providers there.
